Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07195721 · ClinicalTrials.gov registry record
The Effect of PROSE or Scleral Lenses on Mental Health
A clinical trial of Depression - Major Depressive Disorder, sponsored by Boston Sight.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT07195721 is a study of Depression - Major Depressive Disorder that is actively recruiting participants, run by Boston Sight. The registered enrollment target is 200 participants, above the 92-participant average among 19 other Depression - Major Depressive Disorder trials with a reported enrollment target (117% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07195721, a study of Depression - Major Depressive Disorder, is actively recruiting participants, sponsored by Boston Sight.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this prospective clinical trial is to evaluate the effect that prosthetic replacement of the ocular surface ecosystem (PROSE, BostonSight, Needham MA) treatment may have on mental health, particularly affective mood disorders. Correlation between changes in mental health and ocular symptom improvement and/or visual function improvement will be evaluated.
Conditions Studied
Study Locations (1)
Massachusetts
- BostonSight - Needham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-11-11 |
| Est. Completion | 2029-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07195721
The ClinicalTrials.gov registry entry for NCT07195721 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 92-participant average among 19 other Depression - Major Depressive Disorder trials with a reported enrollment target (117% higher). The listed sponsor is Boston Sight, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression - Major Depressive Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT07195721 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07195721 about?
NCT07195721 is a clinical study titled "The Effect of PROSE or Scleral Lenses on Mental Health". The goal of this prospective clinical trial is to evaluate the effect that prosthetic replacement of the ocular surface ecosystem (PROSE, BostonSight, Needham MA) treatment may have on mental health, particularly affective mood disorders. Correlation between changes in mental health and ocular sympt...
What is the current status of trial NCT07195721?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-11-11. Estimated completion is 2029-10-31.
What conditions does trial NCT07195721 study?
This clinical trial studies the following conditions: Depression - Major Depressive Disorder.
Who is sponsoring clinical trial NCT07195721?
This trial is sponsored by Boston Sight, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07195721 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression - Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RECRUITING · Phase 3
-
Open-Label Psilocybin Study in Transdiagnostic Population
RECRUITING · Phase 1
-
Mindful Self-Compassion to Address PTSD and Substance Use in Unhoused Women
RECRUITING · NA
-
Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains
RECRUITING · Phase 1
-
Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.